Maertens, Johan × Groll, Andreas H Cordonnier, Catherine de la Cámara, Rafael Roilides, Emmanuel Marchetti, Oscar #
Oxford University Press
The Journal of Antimicrobial Chemotherapy vol:66 pages:i37-i43
Invasive mould disease is a growing threat for immunocompromised patients. The optimum time to use mould-active antifungal agents is much debated. Current approaches to antifungal prophylaxis, early treatment (empirical and pre-emptive therapy) and treatment of documented mould infections in onco-haematology patients are discussed.